wet AMD - Classic CNVM mild vision loss
|
|
80 year old female She did not notice a problem but then when she saw you her vision in the right eye was hazy. The left eye was being watched because of eyelid herpes. The right eye has always been the weaker eye. She has not noticed a vision change in the right eye.
Shingles post-herpetic neuralgia over left eye for 2 years
VA OD: Dcc20/40+1 NccJ3
VA OS: Dcc20/25-2 NccJ1-1
IOP: TP: OD:17 OS:21
Anterior segment unremarkable (PCIOLs)
Vision improved to 20/25 after two Avastin shots and at 1 year she is getting treatment every 2 months
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 31480 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 31380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 30080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 33580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 32080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 30380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 34280 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29280 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 31480 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 30980 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29880 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 31780 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29480 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 31580 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29980 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 35180 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 32680 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 33180 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 35280 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 31380 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 34980 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 28080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 28080 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 31480 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
Wet age-related macular degeneration - Classic Juxtafoveal Choroidal Neovascular Membranevaatamisi: 29180 year old female with mild vision loss. 20/40 OD, 20/25 OS. Avastin controlled disease. VA improved to 20/25 after 2 injections. At 1 year she is getting every 2 months treatment
(0 hinnangut)
|
|
|
|
|
|
|
80 year old female She did not notice a problem but then when she saw you her vision in the right eye was hazy. The left eye was being watched because of eyelid herpes. The right eye has always been the weaker eye. She has not noticed a vision change in the right eye.
Shingles post-herpetic neuralgia over left eye for 2 years
VA OD: Dcc20/40+1 NccJ3
VA OS: Dcc20/25-2 NccJ1-1
IOP: TP: OD:17 OS:21
Anterior segment unremarkable (PCIOLs)
Vision improved to 20/25 after two Avastin shots and at 1 year she is getting treatment every 2 months
